title: Zika Virus Infection Among U.S. Pregnant Travelers - August 2015-February 2016.
abstract: After reports of microcephaly and other adverse pregnancy outcomes in infants of mothers infected with Zika virus during pregnancy, CDC issued a travel alert on January 15, 2016, advising pregnant women to consider postponing travel to areas with active transmission of Zika virus. On January 19, CDC released interim guidelines for U.S. health care providers caring for pregnant women with travel to an affected area, and an update was released on February 5. As of February 17, CDC had received reports of nine pregnant travelers with laboratory-confirmed Zika virus disease; 10 additional reports of Zika virus disease among pregnant women are currently under investigation. No Zika virus-related hospitalizations or deaths among pregnant women were reported. Pregnancy outcomes among the nine confirmed cases included two early pregnancy losses, two elective terminations, and three live births (two apparently healthy infants and one infant with severe microcephaly); two pregnancies (approximately 18 weeks' and 34 weeks' gestation) are continuing without known complications. Confirmed cases of Zika virus infection were reported among women who had traveled to one or more of the following nine areas with ongoing local transmission of Zika virus: American Samoa, Brazil, El Salvador, Guatemala, Haiti, Honduras, Mexico, Puerto Rico, and Samoa. This report summarizes findings from the nine women with confirmed Zika virus infection during pregnancy, including case reports for four women with various clinical outcomes. U.S. health care providers caring for pregnant women with possible Zika virus exposure during pregnancy should follow CDC guidelines for patient evaluation and management. Zika virus disease is a nationally notifiable condition. CDC has developed a voluntary registry to collect information about U.S. pregnant women with confirmed Zika virus infection and their infants. Information about the registry is in preparation and will be available on the CDC website.
authors.forename: Dana
authors.initials: D
authors.lastname: Meaney-Delman
authors.forename: Susan L
authors.initials: SL
authors.lastname: Hills
authors.forename: Charnetta
authors.initials: C
authors.lastname: Williams
authors.forename: Romeo R
authors.initials: RR
authors.lastname: Galang
authors.forename: Preetha
authors.initials: P
authors.lastname: Iyengar
authors.forename: Andrew K
authors.initials: AK
authors.lastname: Hennenfent
authors.forename: Ingrid B
authors.initials: IB
authors.lastname: Rabe
authors.forename: Amanda
authors.initials: A
authors.lastname: Panella
authors.forename: Titilope
authors.initials: T
authors.lastname: Oduyebo
authors.forename: Margaret A
authors.initials: MA
authors.lastname: Honein
authors.forename: Sherif
authors.initials: S
authors.lastname: Zaki
authors.forename: Nicole
authors.initials: N
authors.lastname: Lindsey
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Lehman
authors.forename: Natalie
authors.initials: N
authors.lastname: Kwit
authors.forename: Jeanne
authors.initials: J
authors.lastname: Bertolli
authors.forename: Sascha
authors.initials: S
authors.lastname: Ellington
authors.forename: Irogue
authors.initials: I
authors.lastname: Igbinosa
authors.forename: Anna A
authors.initials: AA
authors.lastname: Minta
authors.forename: Emily E
authors.initials: EE
authors.lastname: Petersen
authors.forename: Paul
authors.initials: P
authors.lastname: Mead
authors.forename: Sonja A
authors.initials: SA
authors.lastname: Rasmussen
authors.forename: Denise J
authors.initials: DJ
authors.lastname: Jamieson
mesh_terms: D000328:Adult; D002487:Centers for Disease Control and Prevention, U.S.; D005260:Female; D017408:Guidelines as Topic; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis*; D014195:Travel; D014481:United States; D000071244:Zika Virus / Q000302:isolation & purification*; D000071243:Zika Virus Infection / Q000175:diagnosis* / Q000453:epidemiology